Cyclezyme AB

Cyclezyme specializes in biotechnology. The company conducts research and development of enzymes and processes for the degradation of primarily PET-based plastic products found in, for example, packaging, textiles and composite materials. The enzymes and processes are intended for use in plastic recycling. Cyclezyme was founded in 2020 and is headquartered in Lund.

Quotes for Cyclezyme AB

Board

CEO

  • Peter Falck

Chairperson of the Board

  • Martin Bengtsson

Board

  • Javier Linares Pastén
  • Lotta Amsén
  • Peter Falck
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months 2024
Total revenue MSEK 0.00 0.84 0.69 0.00 0.00 0.15 0.00
Earnings before interest and tax MSEK -0.83 -1.54 -0.09 -0.43 -0.67 -0.35 -2.14
Profit before tax MSEK -0.83 -1.58 -0.10 -0.44 -0.68 -0.36 -2.13
Net profit MSEK -0.83 -1.58 -0.10 -0.44 -0.68 -0.36 -2.13
Earnings per share SEK -0.32 -0.67 -0.04 -0.18 -0.28 -0.17 -1.00
Dividend per share SEK 0,00 0.00 0.00 0,00 0,00 0,00 0.00
Equity MSEK 6.92 7.75 7.75 6.12 6.56 4.39 4.75
Fixed assets MSEK 0.24 0.26 0.26 0.19 0.20 0.22 0.23
Intangible assets MSEK 5.57 4.96 4.96 4.39 3.93 3.48 3.07
Current assets MSEK 2.16 3.42 3.42 2.52 3.61 1.84 2.50
Total asset MSEK 7.98 8.64 8.64 7.10 7.74 5.53 5.80
Long term liabilities MSEK 0.18 0.21 0.21 0.24 0.27 0.30 0.36
Current liabilities MSEK 0.88 0.68 0.68 0.74 0.91 0.84 0.70
Number of shares SEK 2589929.00 2589929.00 2589929.00 2439929.00 2439929.00 2139929.00 2139929.00
*Compiled data from Millistream